Artificial Intelligence in Pharmaceuticals, Biologics, and Medical Devices: Present and Future Regulatory Models

Opderbeck, David W.

Journal: Fordham Law Review

Volume: 88

First Page: 553

Year: 2019

Bluebook Citation: 88 FORDHAM L. REV. 553 (2019)

Author: David W. Opderbeck: all 16 publications


Abstract

Artificial intelligence (AI) and AI-assisted technologies are set to transform the pharmaceutical, biologic, and medical device industries. AI is accelerating a convergence in the pharmaceutical and medical device industries and, in the health-care industry more broadly, is similar to the convergence of the media, entertainment, and communications industries.

Chat with this journal article using AI

Ask CiteLaw's AI Navigator anything about this journal article, verify citations, and research related authorities. Sign up for CiteLaw free today to get started.